Furthermore, in a model system of GBM acquired resistance, the uPA/uPAR signalling is required for the repression of the Bim proapoptotic factor, thus promoting resistance to EGFR tyrosine kinase inhibitors (Wykosky et al., 2015). This evidence concerns the gene BCL2L11 and glioblastoma.